Business Context and Reporting Period
This Form 8-K filing by Quantum-Si Inc (QSI) reports on events occurring on March 8, 2024, and March 10, 2024. The Company is a Delaware corporation with principal executive offices in Branford, Connecticut. The filing addresses amendments to performance-based stock option awards for the Chief Executive Officer and Chief Financial Officer.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on executive compensation adjustments.
Material Changes
The Board of Directors and Compensation Committee approved amendments to existing stock option awards to better align vesting terms with the Company's Class A common stock price. The changes are effective as of March 15, 2024.
- Jeffrey Hawkins (CEO): Two awards (1.5X and 3.5X Options) totaling 2,780,000 shares were amended. Vesting is now contingent on the stock price reaching specific thresholds ($6.00, $8.00, $10.00, or $12.00) for 20 out of 30 consecutive trading days within three years of the effective date.
- Jeffry Keyes (CFO): Two awards (1X and 3X Options) totaling 1,000,000 shares were amended. Vesting is now contingent on the stock price reaching specific thresholds ($6.00, $8.00, $10.00, or $12.00) for 20 out of 30 consecutive trading days within three years of the effective date.
Guidance, Outlook, and Risks
The filing does not provide financial guidance, outlook, or management commentary on business operations. The primary risk highlighted is the performance-based nature of the new vesting terms; if the stock price does not meet the specified thresholds within the three-year window, the options will not vest.
Investor Verification Checklist
- Verify the current trading price of QSI Class A common stock relative to the new vesting thresholds ($6.00 to $12.00).
- Confirm the total number of shares subject to the amended awards (3,780,000 shares combined for CEO and CFO).
- Review the original grant dates (November 9, 2022, for CEO; May 15, 2023, for CFO) to understand the historical context of the options.
- Monitor future filings for any further adjustments to the vesting schedule or stock price targets.